Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Medicenna Therapeutics Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 19 | 29 | +10 |
| Shares | 4.50M | 12.4M | +7.95M (+176.8%) |
| Value | $5.41M | $9.67M | +$4.26M (+78.6%) |
New holders (11)
Institutions that held Medicenna Therapeutics Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AWM Investment Company, Inc. | 2,660,000 | $1.55M | 0.24% |
| Hudson Bay Capital Management LP | 1,000,000 | $830.0K | 0.01% |
| DAFNA Capital Management LLC | 660,000 | $548.0K | 0.15% |
| Alyeska Investment Group, L.P. | 650,000 | $539.0K | 0.01% |
| Empery Asset Management, LP | 589,316 | $489.0K | 2.91% |
| Granite Point Capital Management, L.P. | 325,000 | $270.0K | 0.28% |
| Maven Securities LTD | 150,000 | $124.0K | 0.01% |
| Annandale Capital, LLC | 40,000 | $33.0K | 0.01% |
| Warberg Asset Management LLC | 29,500 | $24.0K | 0.01% |
| Newman Dignan & Sheerar, Inc. | 12,915 | $11.0K | 0.00% |
| Bank of America Corp | 1,500 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Medicenna Therapeutics Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 1,464 | $2.00K |